Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564483 · ClinicalTrials.gov registry record
Gynecologic Extramammary Paget's Disease
A clinical trial of Extramammary Paget Disease and Extramammary Paget's Disease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03564483 is a study of Extramammary Paget Disease and Extramammary Paget's Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03564483, a study of Extramammary Paget Disease and Extramammary Paget's Disease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-02-19 |
| Est. Completion | 2050-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03564483
The ClinicalTrials.gov registry entry for NCT03564483 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Extramammary Paget Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03564483 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03564483 about?
NCT03564483 is a clinical study titled "Gynecologic Extramammary Paget's Disease". In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of...
What is the current status of trial NCT03564483?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-02-19. Estimated completion is 2050-12.
What conditions does trial NCT03564483 study?
This clinical trial studies the following conditions: Extramammary Paget Disease, Extramammary Paget's Disease, Paget Disease, Extramammary, Extramammary Paget's Disease of Vulva (Diagnosis), Extramammary Paget's Disease of Vagina (Diagnosis).
Who is sponsoring clinical trial NCT03564483?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03564483 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Extramammary Paget Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.